Endogenous Vascular Endothelial Growth Factor-C Expression Is Associated with Decreased Drug Responsiveness in Childhood Acute Myeloid LeukemiaHendrik J.M. de Jonge, Eveline S.J.M. de Bont, Gertjan J.L. Kaspers et al.|Clinical Cancer Research|2008Cited by 24
Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell deathAlida C. Weidenaar, Eveline S.J.M. de Bont, Hendrik J.M. de Jonge et al.|Anti-Cancer Drugs|2008Cited by 11
Endogenous VEGF-C mRNA Expression Increases In Vitro Drug Resistance of Pediatric AML Cells and Is an Independent Prognostic Factor for the Time To Reach Complete Remission in AML.Hendrik J.M. de Jonge, E. S. J. M. de Bont, Willem A. Kamps et al.|Blood|2006Cited by 1